Pet Cancer Therapeutics Market Efficient Cancer Cure in Companion Animals

Posted by phulkarpareesh on August 16th, 2018

The veterinary pharmaceutical companies are focusing on strategic collaborations to develop and commercialize cancer treatments for companion animals. For instance, in 2017, Karyopharm and Anivive Lifesciences entered into an exclusive global license agreement to research, develop, and commercialize Verdinexor (KPT-335), a drug for the treatment of lymphoma, which is in phase 2b of clinical trials. The U.S. FDA Center for Veterinary Medicine (CVM) has found effectiveness and safety technical sections for Verdinexor complete to support conditional approval under a New Animal Drug Application (NADA) for the treatment of canine lymphoma and granted the Minor Use Minor Species (MUMS) designation to the drug candidate. Also, in 2016, Zenoaq, a Japan-based animal health company collaborated with Nexvet to form a research partnership for the development of monoclonal antibodies (mAbs) for canine cancer treatment.

Get The Holistic SAMPLE With Research Methodology:

https://www.coherentmarketinsights.com/insight/request-sample/1284

Key Takeaways of the Pet Cancer Therapeutics Market:

The global pet cancer therapeutics market is expected to exhibit a CAGR of 7.7% over the forecast period, owing to the presence of high potential market, rising incidence of pet cancers, and increasing pet adoption rates in Europe, Asia Pacific, and Latin America

Among therapy type, chemotherapy segment holds a dominant position in the pet cancer therapeutics market, owing to the easy availability of the drugs, high recommendation by the veterinary doctors for opting chemotherapy, and high number of chemotherapeutic drugs present in the product portfolio of the manufacturers

Among pet type, dog segment holds a dominant position in the pet cancer therapeutics market owing to the higher cancer prevalence in the species as compared to the other pets and higher number of cancer treatments available for dogs in the global market.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr.Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702


Related Articles

Pet Cancer Therapeutics Market Efficient Cancer Cure in Comp
The veterinary pharmaceutical companies are focusing on strategic collaborations to develop and commercialize cancer treatments for companion animals. For instance, in 2017, Karyopharm and Anivive Lifesciences entered into an exclusive global license agreement to research, develop, and commercialize Verdinexor (KPT-335), a drug for the treatment of lymphoma,...

Service Animals, Emotional Support Animals, and Guide Dogs
Sadly, some people are asking irrespective of whether "service animal" laws are getting abused by those that would like to scam the system.There have already been news stories, articles, opinion pieces and other editorials exactly where people rant and complain about people they believe to become abusing the system. You hear some complain that they had to ...

Global Veterinary Products for Companion Animals Market Size,
The Global Veterinary Products for Companion Animals Market Size, Status and Forecast 2022 is a professional and in-depth study on the current state of the Veterinary Products for Companion Animals industry.Firstly, the report provides a basic overview of the industry including definitions, classifications, applications and industry chain stru...

Also See: Therapeutics Market, Pet Cancer, Cancer Therapeutics, Companion Animals, Market, Cancer, Pet

Top Searches - Trending Searches - New Articles - Top Articles - Trending Articles - Featured Articles - Top Members

Link To Directory

Developed by Interfuse - Copyright 2010 - 2018 Uberant.com